Related Experiment Videos
Sulfasalazine-induced pulmonary disease.
Digestive Diseases and Sciences
|September 1, 1985
Summary
Sulfasalazine, used for inflammatory bowel disease, can rarely cause lung complications. This case highlights the importance of considering drug-induced pulmonary disease in patients with new respiratory symptoms.
Area of Science:
- Pulmonology
- Gastroenterology
- Pharmacology
Background:
- Sulfasalazine is a common treatment for inflammatory bowel disease (IBD).
- While generally safe, sulfasalazine can cause various side effects.
- Pulmonary complications associated with sulfasalazine are considered rare.